VC
EIGR
Vivo Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,166
| Closed | -$35K | – | 53 |
|
|
2022
Q1 | $35K | Hold |
4,166
| – | – | ﹤0.01% | 54 |
|
|
2021
Q4 | $22K | Sell |
4,166
-465,422
| -99% | -$2.46M | ﹤0.01% | 55 |
|
|
2021
Q3 | $3.14M | Sell |
469,588
-1,321,669
| -74% | -$8.83M | 0.14% | 54 |
|
|
2021
Q2 | $15.3M | Hold |
1,791,257
| – | – | 0.66% | 30 |
|
|
2021
Q1 | $15.9M | Hold |
1,791,257
| – | – | 0.56% | 36 |
|
|
2020
Q4 | $22M | Hold |
1,791,257
| – | – | 0.98% | 24 |
|
|
2020
Q3 | $14.6M | Hold |
1,791,257
| – | – | 0.84% | 35 |
|
|
2020
Q2 | $17.2M | Hold |
1,791,257
| – | – | 1.23% | 22 |
|
|
2020
Q1 | $12.2M | Buy |
+1,791,257
| New | +$12.2M | 1.1% | 25 |
|
|
2019
Q3 | – | Sell |
-1,791,257
| Closed | -$19M | – | 32 |
|
|
2019
Q2 | $19M | Hold |
1,791,257
| – | – | 1.78% | 17 |
|
|
2019
Q1 | $25M | Hold |
1,791,257
| – | – | 2.5% | 14 |
|
|
2018
Q4 | $18.2M | Hold |
1,791,257
| – | – | 2.32% | 12 |
|
|
2018
Q3 | $21.5M | Hold |
1,791,257
| – | – | 2.17% | 16 |
|
|
2018
Q2 | $21.9M | Hold |
1,791,257
| – | – | 2.82% | 12 |
|
|
2018
Q1 | $17.6M | Hold |
1,791,257
| – | – | 2.5% | 11 |
|
|
2017
Q4 | $25M | Buy |
1,791,257
+4,166
| +0.2% | +$58.1K | 5.35% | 6 |
|
|
2017
Q3 | $19.7M | Hold |
1,787,091
| – | – | 3.97% | 10 |
|
|
2017
Q2 | $14.1M | Hold |
1,787,091
| – | – | 3.56% | 9 |
|
|
2017
Q1 | $20.5M | Hold |
1,787,091
| – | – | 6.02% | 5 |
|
|
2016
Q4 | $20.8M | Hold |
1,787,091
| – | – | 6.86% | 5 |
|
|
2016
Q3 | $23.9M | Buy |
1,787,091
+187,500
| +12% | +$2.51M | 7.46% | 3 |
|
|
2016
Q2 | $31.7M | Sell |
1,599,591
-1
| -0% | -$20 | 8.66% | 3 |
|
|
2016
Q1 | $26.8M | Buy |
+1,599,592
| New | +$26.8M | 6.73% | 5 |
|